Brenntag Specialties signs Southeast Asia agreement with Aker BioMarine

Brenntag, a global market leader in the distribution of chemicals and ingredients, announced a distribution agreement with Aker BioMarine covering supplements including Superba 2, Superba 2 Halal, Superba Boost and Antarctic Krill Oil 2.

Aker BioMarine is a biotechnology innovator and Antarctic krill fishing company dedicated to improving the health of people and the planet. The company develops krill ingredients for nutraceutical, aquaculture and animal feed applications. The company's fully transparent value chain stretches from sustainable krill fishing in pristine Antarctic waters, through its Montevideo logistics center, its Houston production facility and on to customers around the world.

Superba Krill Oil, a product of Aker BioMarine, is a next-generation phospholipid complex containing omega-3s and choline. The natural combination of nutrients provides a wide range of clinically proven health benefits to meet the needs of health-conscious consumers. Powered by phospholipids, Superba Krill ensures the delivery of omega-3 EPA and DHA, as well as choline, to the parts of the body where they are needed most, such as the brain, heart, eyes and liver. Superba Krill Oil is pure, sustainable and traceable, backed by over 50 human studies.

Ross Norris, general manager of Aker BioMarine Asia Pacific, said:"We are pleased to announce our strategic partnership with Brenntag Specialties, which marks an important step forward in our mission to serve the nutraceutical sector in Southeast Asia. This distribution agreement underscores our commitment to delivering high-quality, sustainable Antarctic krill oil products to customers in the region by delivering innovative solutions backed by scientific research. Our products reach a wider audience and have a positive impact on the health and vitality of consumers across Southeast Asia."

Romain Girard, President Pharmaceuticals Asia Pacific, Brenntag Specialties said:"We are delighted to enter into a strategic partnership with Aker BioMarine, a company that places sustainability and health at the core of its values. Aker BioMarine's solutions are innovative, clinically proven and offer multiple health benefits, and we will leverage all our expertise and capabilities to bring these complementary solutions to our customers and consumers in Southeast Asia. This agreement strengthens Brenntag Specialties’ complementary medicine offerings in Southeast Asia and affirms our focus on pharmaceutical and nutraceutical solutions across Asia Pacific."